Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Universidad del Valle
2020
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=28366176002 https://www.redalyc.org/journal/283/28366176002/ https://www.redalyc.org/journal/283/28366176002/html/ https://www.redalyc.org/journal/283/28366176002/28366176002.epub https://www.redalyc.org/journal/283/28366176002/movil |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- COVID-19: The Ivermectin African Enigma Rodrigo Guerrero Luis Eduardo Bravo Edgar Muñoz Elvia Karina Grillo Ardila Esteban Guerrero Medicina 19 COVID ivermectin filariasis albendazole Introduction: The low frequency of cases and deaths from the SARS-CoV-2 COVID-19 virus in some countries of Africa has called our attention about the unusual behavior of this disease. The ivermectin is considered a drug of choice for various parasitic and viral diseases and shown to have in vitro effects against SARS-CoV-2. Aims: Our study aimed to describe SARS-CoV2 infection and death rates in African countries that participated in an intensive Ivermectin mass campaign carried out to control onchocerciasis and compare them with those of countries that did not participate. Methods: Data from 19 countries that participated in the World Health Organization (WHO) sponsored African Programme for Onchocerciasis Control (APOC), from 1995 until 2015, were compared with thirty-five (Non-APOC), countries that were not included. Information was obtained from org.siir.client.entities.ExtLink@b0d83 database. Generalized Poisson regression models were used to obtain estimates of the effect of APOC status on cumulative SARS-CoV-2 infection and mortality rates.Results: After controlling for different factors, including the Human Development Index (HDI), APOC countries (vs. non-APOC), show 28% lower mortality (0.72; 95% CI: 0.67-0.78) and 8% lower rate of infection (0.92; 95% CI: 0.91-0.93) due to COVID-19. Conclusions: The incidence in mortality rates and number of cases is significantly lower among the APOC countries compared to non-APOC countries. That a mass public health preventive campaign against COVID-19 may have taken place, inadvertently, in some African countries with massive community ivermectin use is an attractive hypothesis. Additional studies are needed to confirm it. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28366176002 https://www.redalyc.org/journal/283/28366176002/ https://www.redalyc.org/journal/283/28366176002/html/ https://www.redalyc.org/journal/283/28366176002/28366176002.epub https://www.redalyc.org/journal/283/28366176002/movil 10.25100/cm.v51i4.4613 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.4 Vol.51